Thyroid eye disease with teprotumumab-related hyperglycemia associated with increased growth hormone secretion

JCEM Case Reports · Published 2026-07-02 · DOI 10.1210/jcemcr/luag186

Free full text

Authors (6)

Ken Sugawa, Yuji Hataya, Kimiaki Murabe, Kanta Fujimoto, Toshio Iwakura, Naoki Matsuoka

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Sugawa, K., Hataya, Y., Murabe, K., et al. (2026). Thyroid eye disease with teprotumumab-related hyperglycemia associated with increased growth hormone secretion. JCEM Case Reports. https://doi.org/10.1210/jcemcr/luag186

Related articles

• Refractory severe type B insulin resistance treated with daratumumab · JCEM Case Reports · 2026 · Same journal
• Adrenal insufficiency influences the pattern of thyrotoxicosis toward triiodothyronine predominance · JCEM Case Reports · 2026 · Same journal
• Tumoral calcinosis in a patient with end-stage renal disease · JCEM Case Reports · 2026 · Same journal
• Beyond a single diagnosis: coexisting PAPSS2 brachyolmia and growth hormone deficiency in a child with short stature · JCEM Case Reports · 2026 · Same journal
• SRY -positive 46,XX testicular disorder of sex development in adult monozygotic twins · JCEM Case Reports · 2026 · Same journal
• Normo-hormonal primary hyperparathyroidism presenting with recurrent acute pancreatitis · JCEM Case Reports · 2026 · Same journal
• Insulin autoimmune hypoglycemia unmasking monoclonal gammopathy in type 2 diabetes · JCEM Case Reports · 2026 · Same journal
• Autosomal dominant hypophosphatemic rickets caused by a novel pathogenic variant in FGF23 · JCEM Case Reports · 2026 · Same journal
• Hypothalamic adipsia presenting as persistent hypernatremia after aneurysmal subarachnoid hemorrhage · JCEM Case Reports · 2026 · Same journal
• Adipsic hypernatremia associated with hypothalamic dysfunction and sleep disorders · JCEM Case Reports · 2026 · Same journal